Pharmaceutical Care Management Association (Pcma)

PCMA represents pharmacy benefit managers, who administer the nation's covered Rx benefits

Based in DC

🤖

AI Overview

With $2.0M in lobbying spend across 32 quarterly filings, Pharmaceutical Care Management Association (Pcma) is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$2.0M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$240K
2019	$240K
2020	$240K
2021	$280K
2022	$280K
2023	$280K
2024	$280K
2025	$210K

Issues Lobbied

Health Issues Pharmacy Medicare/Medicaid

Lobbying Firms

Red+blue Strategies

Lobbyists

Melanie Nathanson Megan Marshall Benjamin Klein Kathryn Wise

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Medicare/Medicaid

•H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to access and affordability of prescription medications and policies to combat the opioid crisis in the United States.

•H.R. 6 - Support for Patients and Communities Act - Support for policies that help to fight the opioid epidemic with a focus on safe prescriptions.
•S. 3120 - Helping to End Addiction and Lessen Subst

•H.R. 6 - Support for Patients and Communities Act - Support for policies that help to fight the opioid epidemic with a focus on safe prescriptions in the Medicare program.
•S. 3120 - Helping to End Ad